We love a good poster session. This episode we are joined by Dr. Anthony Accurso to review some of our favorite posters from the American Society of Addiction Medicine’s 2026 Annual Meeting.
All the Posters from ASAM 57
Posters profiled here:
12: Real-World Analysis of Buprenorphine-Precipitated Opioid Withdrawal: A Multicenter Study
38: Co-Located Bridge Clinic/Withdrawal Management Unit Reduces 30-Day Readmits Using LA-Bup Injections
55: Increased Naltrexone Prescribed for Alcohol Use After Changes to Obesity Treatment Protocol
62: Comorbidities and Mortality in Substance Use Disorder Patients With Nicotine Dependence
115: Higher Buprenorphine Doses Improve Treatment Engagement and Outcomes in Opioid Use Disorder
119: Closing the Gap: Inpatient Methadone and Telehealth OTP Enrollment
142: Naltrexone Treatment for AI Chatbot Addiction in Adolescent With ASD and ADHD
---
Original theme music: composed and performed by Benjamin Kennedy
Audio editing: Michael Bonanno
Executive producer: Dr. Patrick Beeman
A podcast from Ars Longa Media
---
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group.
---
Email: addictionmedicinejournalclub@gmail.com
Facebook: @AddictionMedJC
Facebook Group: Addiction Medicine Journal Club
Instagram: @AddictionMedJC
Threads: @AddictionMedJC
YouTube: addictionmedicinejournalclub
Twitter/X: @AddictionMedJC
---
Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
Learn more about your ad choices. Visit megaphone.fm/adchoices
